The contribution of the intensive care pharmacist in the United Kingdom

Pharmaceutical Journal

Volumn 265, Issue 7112, 2000, Pages 341-344

  Timmins, Alan ^a  

^a QUEEN MARGARET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347467593     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Vogel DP. Patient-focused care. Am J Hosp Pharm 1993;50: 2321-9.
2. MacLean D. Defining a niche for the renal pharmacist. Hosp Pharm 1994;1:20-2.
3. Mental health outreach programmes. Pharm J 1996;257:86.
4. Dasta JF. Critical care therapeutics: a frontier for clinical pharmacy. Drug Intell Clin Pharm 1982;16:398-9.
5. Dasta JF, Angaran MD. Evolving role of the pharmacist in critical care. Crit Care Med 1992;20:563-5.
6. Dasta JF. Critical care pharmacy update. Ann Pharmacother 1992;26:823-5.
7. ASHP supplemental standard and learning objectives for residency training in critical care pharmacy practice. Am J Hosp Pharm 1990;47:609-12.
8. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994;22: 1044-8.
9. Baldinger SL, Chow MSS, Gannon RH, Kelly ET. Cost savings from having a clinical pharmacist work part-time in a medical intensive care unit. Am J Health Syst Pharm 1997;54: 2811-4.
10. Leape LL. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
11. Sani MH, Bihari DJ. The specialist critical care pharmacist. Hosp Pharm 1995;2:37-9.
12. Cadman B, Park GR. Reducing the risk of IV drug administration to the critically ill patient. Hosp Pharm 1999;6:213-8.
13. Standards for intensive care units. London: Intensive Care Society, 1997.
14. Lee A, Bateman N, Edwards C, Smith JM, Rawlins MD. Reporting of adverse drug reactions by hospital pharmacists: pilot scheme. BMJ 1997;315:519.
15. Seneff MG, Zimmerman JE, Knaus WA. Using the APACHE II system to improve the quality of intensive care. Br J Intensive Care 1997;7:231-236.
16. Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics and paralytics in the ICU. Ann Pharmacother 1997;31:148-53.
17. Park GR, Gray PA. Infusions of analgesics, sedatives and muscle relaxants in patients who require intensive care. Anaesthesia 1989;44:879-80.
18. Aitkenhead AR, Peppennan ML, Willatts SM, Coates PD, Park GR, Bodenham AR et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989; ii:704-9.
19. Devlin JW, Holbrook AM, Fuller HD. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother 1997;31:689-95.